PRWeb
Debut Biotech Raises $22.6M Series A to Commercialize High-Value Ingredients from Proprietary Cell-Free Biomanufacturing Platform
Novel ingredients bring unique advantages to cosmetic, food, and health and wellness markets in one of the largest Series A financing rounds in synthetic biology space
Cosmetics Design
Debut Biotechnology partners with DIC on cosmetic pigment production
Biotech promises to be the future of chemical synthesis and is already used to manufacture numerous cosmetics and personal care ingredients. The Debut-DIC deal is on track to deliver not only a new source for cosmetics pigments but also to showcase a new sort of biotech platform.
Business Insider
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months
Every day seems to bring a fundraising record and a new company launching in the biotech industry. Insider spoke with some of the smartest and most plugged-in venture capitalists in biotech to pinpoint the most exciting startups.
Food Navigator
Food ingredients startups to watch, from rare sugars and prebiotic fibers to ‘cell-free’ biomanufacturing
From San Diego-based Debut Biotech, which is developing a range of high-value ingredients via a novel ‘cell-free’ biomanufacturing platform, to Virginia-based Bonumose, which has patented technology it claims could enable the “mass market adoption” of rare sugars.
